Epstein-barr virus diversity in immunocompetent healthy persons: Reassessment of the distribution of genetic variants

Journal of Medical Virology

Volumn 86, Issue 2, 2014, Pages 301-305

  Ikeda, Tetsuya ^a   Kobayashi, Ryo ^b   Kogashiwa, Yasunao ^a   Matsuda, Takehiro ^a   Kohno, Naoyuki ^a  

^a KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Tokyo Medical University School of Medicine   (Japan)

Author keywords

B95 8; EBV; Healthy persons; P3HR1; Strain

Indexed keywords

GENOMIC DNA; VIRUS DNA;

ADENOID; ARTICLE; CHRONIC TONSILLITIS; CLINICAL ARTICLE; EPSTEIN BARR VIRUS; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HISTOLOGY; HUMAN; HUMAN TISSUE; LYMPHOCYTE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; TANDEM REPEAT; TONSIL; VIRUS DETECTION; VIRUS STRAIN;

HUMAN HERPESVIRUS 4;

B95-8; EBV; HEALTHY PERSONS; P3HR1; STRAIN;

ADENOIDS; COINFECTION; EPSTEIN-BARR VIRUS INFECTIONS; GENETIC VARIATION; HEALTHY VOLUNTEERS; HERPESVIRUS 4, HUMAN; HUMANS; INTRONS; LYMPHOCYTES; PALATINE TONSIL; TRANS-ACTIVATORS;

EID: 84890173613     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23715     Document Type: Article

References (40)

1. Baer R, Bankier AT, Biggin MD, Deininger PL, Farrell PJ, Gibson TJ, Hatfull G, Hudson GS, Satchwell SC, Seguin C, Tuffnell PS, Barrel BG. 1984. DNA sequence and expression of the B 95-8 Epstein-Barr virus genome. Nature 310:207-211.
2. Bornkamm GW, Hudewentz J, Freese UK, Zimber U. 1982. Deletion of the nontransforming Epstein-Barr virus strain p3hr-1 causes fusion of the large internal repeat to the dsl region. J Virol 43:952-968.
3. Brandwein M, Nuovo G, Ramer M, Orlowski W, Miller L. 1996. Epstein-Barr virus reactivation in hairy leukoplakia. Mod Pathol 9:298-303.
4. Chang YS, Su IJ, Chung PJ, Shu CH, Ng CK, Wu SJ, Liu ST. 1995. Detection of an Epstein-Barr-virus variant in t-cell-lymphoma tissues identical to the distinct strain observed in nasopharyngeal carcinoma in the taiwanese population. Int J Cancer 62:673-677.
5. Chen HL, Lung ML, Chan KH, Griffin BE, Ng MH. 1996. Tissue distribution of Epstein-Barr virus genotypes. J Virol 70:7301-7305.
6. Chen ML, Tsai CN, Liang CL, Shu CH, Huang CR, Sulitzeanu D, Liu ST, Chang YS. 1992. Cloning and characterization of the latent membrane protein (lmp) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the taiwanese population. Oncogene 7:2131-2140.
7. Chen JN, Ding YG, Feng ZY, Li HG, He D, Du H, Wu B, Shao CK. 2010. Association of distinctive Epstein-Barr virus variants with gastric carcinoma in Guangzhou, Southern China. J Med Virol 82:658-667.
8. Cheung ST, Lo KW, Leung SF, Chan WY, Choi PH, Johnson PJ, Lee JC, Huang DP. 1996. Prevalence of lmp1 deletion variant of Epstein-Barr virus in nasopharyngeal carcinoma and gastric tumors in Hong Kong. Int J Cancer 66:711-712.
9. Cohen JI, Wang F, Kieff E. 1991. Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation. J Virol 65:2545-2554.
10. Dambaugh T, Hennessy K, Chamnankit L, Kieff E. 1984. U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2. Proc Natl Acad Sci USA 81:7632-7636.
11. de Campos-Lima PO, Gavioli R, Zhang QJ, Wallace LE, Dolcetti R, Rowe M, Rickinson AB, Masucci MG. 1993. Hla-a11 epitope loss isolates of Epstein-Barr virus from a highly a11+ population. Science 260:98-100.
12. de Campos-Lima PO, Levitsky V, Brooks J, Lee SP, Hu LF, Rickinson AB, Masucci MG. 1994. T cell responses and virus evolution: Loss of hla a11-restricted ctl epitopes in Epstein-Barr virus isolates from highly a11-positive populations by selective mutation of anchor residues. J Exp Med 179:1297-1305.
13. Farrell PJ. 1993. Epstein-Barr virus. In: O'Brien SJ, editor. Genetic maps. 6th edition. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press, Inc. p120-133.
14. Geser A, de The G, Lenoir G, Day NE, Williams EH. 1982. Final case reporting from the Ugandan prospective study of the relationship between EBV and Burkitt's lymphoma. Int J Cancer 29:397-400.
15. Gratama JW, Oosterveer MA, Weimar W, Sintnicolaas K, Sizoo W, Bolhuis RL, Ernberg I. 1994. Detection of multiple 'ebnotypes' in individual Epstein-Barr virus carriers following lymphocyte transformation by virus derived from peripheral blood and oropharynx. J Gen Virol 75:85-94.
16. Hu LF, Zabarovsky ER, Chen F, Cao SL, Ernberg I, Klein G, Winberg G. 1991. Isolation and sequencing of the Epstein-Barr virus bnlf-1 gene (lmp1) from a chinese nasopharyngeal carcinoma. J Gen Virol 72:2399-2409.
17. Ikeda T, Kobayashi R, Horiuchi M, Nagata Y, Hasegawa M, Mizuno F, Hirai K. 2000. Detection of lymphocytes productively infected with Epstein-Barr virus in non-neoplastic tonsils. J Gen Virol 81:1211-1216.
18. Jenson HB, Miller G. 1988. Polymorphisms of the region of the Epstein-Barr virus genome which disrupts latency. Virology 165:549-564.
19. Kieff E, Rickinson AB. 2007. Epstein-Barr virus and its replication. In: Knipe DM, Howley PM, editors. Fields virology. 5th edition. Philadelphia: Lippincott Williams and Wilkins, Inc. pp 2603-2654.
20. Knecht H, Raphael M, McQuain C, Rothenberger S, Pihan G, Camilleri-Broet S, Bachmann E, Kershaw GR, Ryan S, Kittler EL, Quesenberry PJ, Schlaifer D, Woda BA, Brousset P. 1996. Deletion variants within the nf-kappa b activation domain of the lmp1 oncogene prevail in acquired immunodeficiency syndrome-related large cell lymphomas and human immunodeficiency virus-negative atypical lymphoproliferations. Blood 87:876-881.
21. Laichalk LL, Thorley-Lawson DA. 2005. Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J Virol 79:1296-1307.
22. Leung SY, Yuen ST, Chung LP, Chan AS, Wong MP. 1997. Prevalence of mutations and 30-bp deletion in the c-terminal region of Epstein-Barr virus latent membrane protein-1 oncogene in reactive lymphoid tissue and non-nasopharyngeal ebv-associated carcinomas in Hong Kong chinese. Int J Cancer 72:225-230.
23. Levine PH, Stemmermann G, Lennette ET, Hildesheim A, Shibata D, Nomura A. 1995. Elevated antibody titers to Epstein-Barr virus prior to the diagnosis of Epstein-Barr virus-associated gastric adenocarcinoma. Int J Cancer 60:642-644.
24. Mueller N, Evans A, Harris NL, Comstock GW, Jellum E, Magnus K, Orentreich N, Polk BF, Vogelman J. 1989. Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis. N Engl J Med 320:689-695.
25. Mueller N, Mohar A, Evans A, Harris NL, Comstock GW, Jellum E, Magnus K, Orentreich N, Polk PF, Vogelman J. 1991. Epstein-Barr virus antibody patterns preceding the diagnosis of non-Hodgkin's lymphoma. Int J Cancer 49:387-393.
26. Murray RJ, Young LS, Calender A, Gregory CD, Rowe M, Lenoir GM, Rickinson AB. 1988. Different patterns of Epstein-Barr virus gene expression and of cytotoxic T-cell recognition in B-cell lines infected with transforming (B95.8) or nontransforming (P3HR1) virus strains. J Virol 62:894-901.
27. Niedobitek G, Young LS. 1994. Epstein-Barr virus persistence and virus-associated tumours. Lancet 343:333-335.
28. Palefsky JM, Berline J, Greenspan D, Greenspan JS. 2002. Evidence for trafficking of Epstein-Barr virus strains between hairy leukoplakia and peripheral blood lymphocytes. J Gen Virol 83:317-321.
29. Plaza G, Santon A, Bellas C. 2003. Coinfection by multiple strains of Epstein-Barr virus in infectious mononucleosis in immunocompetent patients. Acta Otolaryngol 123:543-546.
30. Qin HD, Jia WH, Zhang LL, Liu N, Zhou XX, Wang MH, Feng QS, Chen LZ, Zhang Y, Jorgensen TJ, Zeng YX, Shugart YY. 2011. Elevated Epstein-Barr virus seroreactivity among unaffected members of families with nasopharyngeal carcinoma. J Med Virol 83:1792-1798.
31. Sample J, Young L, Martin B, Chatman T, Kieff E, Rickinson A. 1990. Epstein-Barr virus types 1 and 2 differ in their ebna-3a, ebna-3b, and ebna-3c genes. J Virol 64:4084-4092.
32. Shinkura R, Yamamoto N, Koriyama C, Shinmura Y, Eizuru Y, Tokunaga M. 2000. Epstein-Barr virus-specific antibodies in Epstein-Barr virus-positive and -negative gastric carcinoma cases in Japan. J Med Virol 60:411-416.
33. Srivastava G, Wong KY, Chiang AK, Lam KY, Tao Q. 2000. Coinfection of multiple strains of Epstein-Barr virus in immunocompetent normal individuals: Reassessment of the viral carrier state. Blood 95:2443-2445.
34. Walling DM, Edmiston SN, Sixbey JW, Abdel-Hamid M, Resnick L, Raab-Traub N. 1992. Coinfection with multiple strains of the Epstein-Barr virus in human immunodeficiency virus-associated hairy leukoplakia. Proc Natl Acad Sci USA 89:6560-6564.
35. Walling DM, Raab-Traub N. 1994. Epstein-Barr virus intrastrain recombination in oral hairy leukoplakia. J Virol 68:7909-7917.
36. Walling DM, Perkins AG, Webster-Cyriaque J, Resnick L, Raab-Traub N. 1994. The Epstein-Barr virus ebna-2 gene in oral hairy leukoplakia: Strain variation, genetic recombination, and transcriptional expression. J Virol 68:7918-7926.
37. Walling DM, Clark NM, Markovitz DM, Frank TS, Braun DK, Eisenberg E, Krutchkoff DJ, Felix DH, Raab-Traub N. 1995. Epstein-Barr virus coinfection and recombination in non-human immunodeficiency virus-associated oral hairy leukoplakia. J Infect Dis 171:1122-1130.
38. Yao QY, Rowe M, Martin B, Young LS, Rickinson AB. 1991. The Epstein-Barr virus carrier state: Dominance of a single growth-transforming isolate in the blood and in the oropharynx of healthy virus carriers. J Gen Virol 72:1579-1590.
39. Young LS, Dawson CW, Clark D, Rupani H, Busson P, Tursz T, Johnson A, Rickinson AB. 1988. Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J Gen Virol 69:1051-1065.
40. Zeng Y, Zhang LG, Wu YC, Huang YS, Huang NQ, Li JY, Wang YB, Jiang MK, Fang Z, Meng NN. 1985. Prospective studies on nasopharyngeal carcinoma in Epstein-Barr virus IgA/VCA antibody-positive persons in Wuzhou City, China. Int J Cancer 36:545-547.